1. Home
  2. RAPP vs PRCT Comparison

RAPP vs PRCT Comparison

Compare RAPP & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$36.56

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$25.07

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAPP
PRCT
Founded
2022
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
RAPP
PRCT
Price
$36.56
$25.07
Analyst Decision
Strong Buy
Buy
Analyst Count
6
11
Target Price
$48.50
$35.44
AVG Volume (30 Days)
251.7K
1.2M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
24.34
1.71
EPS
N/A
N/A
Revenue
N/A
$308,054,000.00
Revenue This Year
N/A
$31.34
Revenue Next Year
N/A
$24.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
37.22
52 Week Low
$7.73
$19.35
52 Week High
$42.27
$64.89

Technical Indicators

Market Signals
Indicator
RAPP
PRCT
Relative Strength Index (RSI) 74.25 50.54
Support Level $25.48 $19.35
Resistance Level $42.27 $28.07
Average True Range (ATR) 1.93 1.36
MACD 0.60 0.08
Stochastic Oscillator 97.74 56.67

Price Performance

Historical Comparison
RAPP
PRCT

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: